Clarivate Plc (CLVT) | Financial Analysis & Statements
Clarivate Plc Small-cap Technology
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
617.0M
Gross Profit
412.2M
66.81%
Operating Income
58.0M
9.40%
Net Income
3.1M
0.50%
EPS (Diluted)
$0.00
Balance Sheet Metrics
Total Assets
11.1B
Total Liabilities
6.2B
Shareholders Equity
4.8B
Debt to Equity
1.29
Cash Flow Metrics
Operating Cash Flow
198.8M
Free Cash Flow
89.2M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Clarivate Plc Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 2.5B | 2.6B | 2.6B | 2.7B | 1.9B |
| Cost of Goods Sold | 833.6M | 869.2M | 906.4M | 954.0M | 626.1M |
| Gross Profit | 1.6B | 1.7B | 1.7B | 1.7B | 1.3B |
| Gross Margin % | 66.0% | 66.0% | 65.5% | 64.1% | 66.6% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 708.6M | 727.6M | 739.7M | 729.9M | 643.0M |
| Other Operating Expenses | -16.3M | 1.3M | -300.0K | -900.0K | 7.9M |
| Total Operating Expenses | 692.3M | 728.9M | 739.4M | 729.0M | 650.9M |
| Operating Income | 172.1M | 231.6M | 274.7M | 266.3M | 62.1M |
| Operating Margin % | 7.0% | 9.1% | 10.4% | 10.0% | 3.3% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 265.4M | 283.4M | 293.7M | 270.3M | 252.5M |
| Other Non-Operating Income | -100.6M | -624.4M | -993.5M | -4.0B | -67.8M |
| Pre-tax Income | -193.9M | -553.8M | -1.0B | -4.0B | -258.2M |
| Income Tax | 7.2M | 82.9M | -101.3M | -28.9M | 12.3M |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Income | -201.1M | -636.7M | -911.2M | -4.0B | -270.5M |
| Net Margin % | -8.2% | -24.9% | -34.7% | -148.9% | -14.4% |
| Key Metrics | |||||
| EBITDA | 929.3M | 1.1B | 983.0M | 976.8M | 599.9M |
| EPS (Basic) | $-0.30 | $-0.96 | $-1.47 | $-5.97 | $-0.49 |
| EPS (Diluted) | $-0.30 | $-0.96 | $-1.47 | $-6.24 | $-0.61 |
| Basic Shares Outstanding | 673300000 | 693600000 | 671600000 | 676100000 | 630976906 |
| Diluted Shares Outstanding | 673300000 | 693600000 | 671600000 | 676100000 | 630976906 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Clarivate Plc Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 329.2M | 295.2M | 370.7M | 356.8M | 430.9M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 821.7M | 798.3M | 908.3M | 872.1M | 906.4M |
| Inventory | - | - | - | - | - |
| Other Current Assets | 64.9M | 65.2M | 68.0M | 76.9M | 66.6M |
| Total Current Assets | 1.3B | 1.2B | 1.5B | 1.4B | 1.6B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 56.9M | 63.8M | 65.5M | 69.0M | 145.2M |
| Goodwill | 11.1B | 11.6B | 13.1B | 15.2B | 26.2B |
| Intangible Assets | 8.0B | 8.4B | 9.0B | 9.4B | 10.4B |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 85.3M | 130.7M | 107.5M | 122.1M | 78.7M |
| Total Non-Current Assets | 9.8B | 10.2B | 11.2B | 12.5B | 18.5B |
| Total Assets | 11.1B | 11.5B | 12.7B | 13.9B | 20.2B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 150.6M | 124.5M | 144.1M | 101.4M | 129.2M |
| Short-term Debt | 119.9M | 20.6M | 24.4M | 25.7M | 62.8M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | 6.7M | - | - |
| Total Current Liabilities | 1.6B | 1.4B | 1.6B | 1.6B | 1.9B |
| Non-Current Liabilities | |||||
| Long-term Debt | 4.4B | 4.6B | 4.8B | 5.1B | 5.6B |
| Deferred Tax Liabilities | 212.1M | 273.3M | 249.6M | 316.1M | 380.1M |
| Other Non-Current Liabilities | 86.2M | 55.9M | 41.9M | 140.1M | 142.7M |
| Total Non-Current Liabilities | 4.7B | 4.9B | 5.1B | 5.6B | 6.4B |
| Total Liabilities | 6.2B | 6.4B | 6.7B | 7.1B | 8.3B |
| Equity | |||||
| Common Stock | 12.8B | 13.0B | 11.7B | 11.7B | 11.8B |
| Retained Earnings | -7.5B | -7.3B | -6.6B | -5.7B | -1.6B |
| Treasury Stock | - | - | - | 0 | 16.9M |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 4.8B | 5.1B | 6.0B | 6.8B | 11.9B |
| Key Metrics | |||||
| Total Debt | 4.5B | 4.6B | 4.8B | 5.1B | 5.6B |
| Working Capital | -258.8M | -188.9M | -137.8M | -164.6M | -264.8M |
Balance Sheet Composition
Clarivate Plc Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -201.1M | -636.7M | -911.2M | -4.0B | -270.5M |
| Depreciation & Amortization | 757.2M | 727.0M | 708.3M | 710.5M | 537.8M |
| Stock-Based Compensation | 63.1M | 59.9M | 109.0M | 93.9M | 33.3M |
| Working Capital Changes | 22.3M | -30.2M | -17.7M | -140.4M | -20.6M |
| Operating Cash Flow | 647.3M | 701.2M | 802.8M | 1.1B | 316.5M |
| Investing Activities | |||||
| Capital Expenditures | - | - | - | - | - |
| Acquisitions | 0 | 52.4M | 5.1M | 260.2M | -3.9B |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | 0 | 52.4M | 5.1M | 260.2M | -3.9B |
| Financing Activities | |||||
| Share Repurchases | -224.5M | -200.0M | -100.0M | -175.0M | -159.4M |
| Dividends Paid | 0 | -37.7M | -75.5M | -75.4M | -18.9M |
| Debt Issuance | 500.0M | - | 0 | 0 | 1.8B |
| Debt Repayment | -600.0M | -198.1M | -301.0M | -498.4M | -28.8M |
| Financing Cash Flow | -343.1M | -470.1M | -497.0M | -935.1M | 4.0B |
| Free Cash Flow | 365.3M | 357.5M | 501.7M | 306.4M | 205.3M |
| Net Change in Cash | 304.2M | 283.5M | 310.9M | 451.2M | 404.1M |
Cash Flow Trend
Clarivate Plc Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
30.75
Forward P/E
3.49
Price to Book
0.36
Price to Sales
0.71
PEG Ratio
3.49
Profitability Ratios
Profit Margin
-8.19%
Operating Margin
9.40%
Return on Equity
-4.03%
Return on Assets
0.95%
Financial Health
Current Ratio
0.84
Debt to Equity
92.57
Beta
1.40
Per Share Data
EPS (TTM)
$-0.30
Book Value per Share
$7.56
Revenue per Share
$3.65
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| CLVT | 1.6B | 30.75 | 0.36 | -4.03% | -8.19% | 92.57 |
| International | 216.8B | 22.93 | 7.34 | 35.16% | 15.69% | 197.33 |
| Accenture plc | 109.7B | 14.61 | 3.51 | 24.76% | 10.61% | 25.47 |
| Globant S.A | 1.8B | 18.20 | 0.87 | 4.96% | 4.19% | 24.23 |
| BigBear.ai Holdings | 1.8B | -4.52 | 2.64 | -96.66% | -230.21% | 18.76 |
| Concentrix | 1.6B | 8.30 | 0.58 | -38.92% | -13.34% | 204.04 |
Financial data is updated regularly. All figures are in the company's reporting currency.






